Loomis Sayles & Co. L P increased its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 558,715 shares of the medical equipment provider's stock after acquiring an additional 20,688 shares during the period. Loomis Sayles & Co. L P owned about 1.67% of Integer worth $74,041,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the stock. Intech Investment Management LLC bought a new stake in Integer in the 3rd quarter valued at approximately $1,012,000. Charles Schwab Investment Management Inc. lifted its position in shares of Integer by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider's stock worth $52,524,000 after purchasing an additional 4,946 shares in the last quarter. Cerity Partners LLC boosted its holdings in Integer by 11.5% during the third quarter. Cerity Partners LLC now owns 32,961 shares of the medical equipment provider's stock worth $4,285,000 after purchasing an additional 3,389 shares during the last quarter. Larson Financial Group LLC grew its position in Integer by 20,000.0% in the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider's stock valued at $131,000 after purchasing an additional 1,000 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its stake in Integer by 5.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 189,919 shares of the medical equipment provider's stock valued at $24,689,000 after buying an additional 9,057 shares during the last quarter. 99.29% of the stock is owned by institutional investors.
Integer Stock Performance
ITGR stock traded down $0.64 during midday trading on Monday, reaching $116.31. 100,113 shares of the company were exchanged, compared to its average volume of 324,292. The business has a 50-day moving average price of $130.47 and a two-hundred day moving average price of $132.09. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 34.62, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. Integer Holdings Co. has a one year low of $107.11 and a one year high of $146.36.
Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Equities research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Wells Fargo & Company reissued an "overweight" rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Citigroup boosted their price target on Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Raymond James started coverage on Integer in a report on Friday. They issued an "outperform" rating and a $145.00 price objective for the company. Finally, Benchmark boosted their target price on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $148.56.
Check Out Our Latest Research Report on Integer
Integer Company Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
